If orforglipron can be manufactured at scale for a fraction of the cost of injectable alternatives, and if its oral format eliminates the injection barriers that prevent millions from starting therapy, the public health impact could be measured in reduced cardiovascular events, fewer diabetes-related amputations, decreased obesity-related cancer incidence, and extended healthy lifespan across populations
These fluctuations may be a sign of an underlying endocrine condition, such as thyroid dysfunction, that needs prompt attention
Circulation 116 (1), 3948
Beyond the dangers of taking an unregulated drug are the social implications of such chemicals being so readily available
For tanning skin: the typical dosage of melanotan-II is 0.025 mg/kg
What are the expected benefits and risks